Cargando…

Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin

To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ran, Wang, Yonglu, Li, Xueming, Bao, Wen, Xia, Guohua, Chen, Wei, Cheng, Jian, Xu, Yuanlong, Guo, Liting, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448924/
https://www.ncbi.nlm.nih.gov/pubmed/26045659
http://dx.doi.org/10.2147/DDDT.S80948
_version_ 1782373790040195072
author Liu, Ran
Wang, Yonglu
Li, Xueming
Bao, Wen
Xia, Guohua
Chen, Wei
Cheng, Jian
Xu, Yuanlong
Guo, Liting
Chen, Baoan
author_facet Liu, Ran
Wang, Yonglu
Li, Xueming
Bao, Wen
Xia, Guohua
Chen, Wei
Cheng, Jian
Xu, Yuanlong
Guo, Liting
Chen, Baoan
author_sort Liu, Ran
collection PubMed
description To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethylene glycol (PEG) was synthesized and then loaded with DNR and Tet simultaneously to construct DNR/Tet–PLGA–PLL–PEG-NPs using a modified double-emulsion solvent evaporation/diffusion method. And to increase the targeted antitumor effect, DNR/Tet–PLGA–PLL–PEG-NPs were further modified with transferrin (Tf) due to its specific binding to Tf receptors (TfR), which is highly expressed on the surface of tumor cells. In this study, the influence of the diversity of formulation parameters was investigated systematically, such as drug loading, mean particle size, molecular weight, the concentration of PLGA–PLL–PEG–Tf, volume ratio of acetone to dichloromethane, the concentration of polyvinyl alcohol (PVA) in the external aqueous phase, the volume ratio of the internal aqueous phase to the external aqueous phase, and the type of surfactants in the internal aqueous phase. Meanwhile, its possible effect on cell viability was evaluated. Our results showed that the regular spherical DNR/Tet–PLGA–PLL–PEG–Tf-NPs with a smooth surface, a relatively low polydispersity index, and a diameter of 213.0±12.0 nm could be produced. The encapsulation efficiency was 70.23%±1.91% for DNR and 86.5%±0.70% for Tet, the moderate drug loading was 3.63%±0.15% for DNR and 4.27%±0.13% for Tet. Notably, the accumulated release of DNR and Tet could be sustained over 1 week, and the Tf content was 2.18%±0.04%. In cell viability tests, DNR/Tet–PLGA–PLL–PEG–Tf-NPs could inhibit the proliferation of K562/ADR cells in a dose-dependent manner, and the half maximal inhibitory concentration value (total drug) of DNR/Tet–PLGA–PLL–PEG–Tf-NPs was lower than that of DNR, a mixture of DNR and Tet, and DNR/Tet–PLGA–PLL–PEG-NPs. These results clearly indicate that the PLGA–PLL–PEG formulation is a potential drug delivery system for hydrophilic and hydrophobic drugs, and that Tf modification may increase its targeting properties.
format Online
Article
Text
id pubmed-4448924
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44489242015-06-04 Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin Liu, Ran Wang, Yonglu Li, Xueming Bao, Wen Xia, Guohua Chen, Wei Cheng, Jian Xu, Yuanlong Guo, Liting Chen, Baoan Drug Des Devel Ther Original Research To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethylene glycol (PEG) was synthesized and then loaded with DNR and Tet simultaneously to construct DNR/Tet–PLGA–PLL–PEG-NPs using a modified double-emulsion solvent evaporation/diffusion method. And to increase the targeted antitumor effect, DNR/Tet–PLGA–PLL–PEG-NPs were further modified with transferrin (Tf) due to its specific binding to Tf receptors (TfR), which is highly expressed on the surface of tumor cells. In this study, the influence of the diversity of formulation parameters was investigated systematically, such as drug loading, mean particle size, molecular weight, the concentration of PLGA–PLL–PEG–Tf, volume ratio of acetone to dichloromethane, the concentration of polyvinyl alcohol (PVA) in the external aqueous phase, the volume ratio of the internal aqueous phase to the external aqueous phase, and the type of surfactants in the internal aqueous phase. Meanwhile, its possible effect on cell viability was evaluated. Our results showed that the regular spherical DNR/Tet–PLGA–PLL–PEG–Tf-NPs with a smooth surface, a relatively low polydispersity index, and a diameter of 213.0±12.0 nm could be produced. The encapsulation efficiency was 70.23%±1.91% for DNR and 86.5%±0.70% for Tet, the moderate drug loading was 3.63%±0.15% for DNR and 4.27%±0.13% for Tet. Notably, the accumulated release of DNR and Tet could be sustained over 1 week, and the Tf content was 2.18%±0.04%. In cell viability tests, DNR/Tet–PLGA–PLL–PEG–Tf-NPs could inhibit the proliferation of K562/ADR cells in a dose-dependent manner, and the half maximal inhibitory concentration value (total drug) of DNR/Tet–PLGA–PLL–PEG–Tf-NPs was lower than that of DNR, a mixture of DNR and Tet, and DNR/Tet–PLGA–PLL–PEG-NPs. These results clearly indicate that the PLGA–PLL–PEG formulation is a potential drug delivery system for hydrophilic and hydrophobic drugs, and that Tf modification may increase its targeting properties. Dove Medical Press 2015-05-22 /pmc/articles/PMC4448924/ /pubmed/26045659 http://dx.doi.org/10.2147/DDDT.S80948 Text en © 2015 Liu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Liu, Ran
Wang, Yonglu
Li, Xueming
Bao, Wen
Xia, Guohua
Chen, Wei
Cheng, Jian
Xu, Yuanlong
Guo, Liting
Chen, Baoan
Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
title Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
title_full Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
title_fullStr Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
title_full_unstemmed Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
title_short Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
title_sort synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448924/
https://www.ncbi.nlm.nih.gov/pubmed/26045659
http://dx.doi.org/10.2147/DDDT.S80948
work_keys_str_mv AT liuran synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT wangyonglu synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT lixueming synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT baowen synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT xiaguohua synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT chenwei synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT chengjian synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT xuyuanlong synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT guoliting synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin
AT chenbaoan synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin